5500 FLATIRON PARKWAY
BOULDER CO 80301
Business Phone: (303) 625-5000
• BOULDER, CO How do I update this listing?
Clovis Oncology is based out of Boulder. Clovis Oncology, Inc. develops and commercializes anti-cancer pharmaceutical drugs. The company develops CO-101, a lipid-conjugated form of the anti-cancer drug gemcitabine, which is in Phase III clinical trials for first-line treatment of metastatic pancreatic cancer; Phase II clinical trials for second-line treatment of metastatic pancreatic cancer; and preclinical trials for solid tumors. Its products also include CO-1686, a small molecule epidermal growth factor receptor, which is in preclinical trials for the treatment of non-small cell lung cancer; and CO-338, a small molecule PARP inhibitor, which is in Phase II clinical trials for the adjuvant treatment of hereditary, or germ-line, BRCA mutant, and triple-negative breast cancer, as well as Phase I clinical trials for the treatment of solid tumors. The company intends to sell its products through distributors in the United States, Europe, and internationally. Clovis Oncology, Inc. was founded in 2009 and is based in Boulder, Colorado.Whalewisdom has at least 1 13G filings, and 145 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2013-11-27. The notice included securities offered of Equity